Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2046Neoplasms 1460Carcinoma, Non-Small-Cell Lung 1365Prostatic Neoplasms 1106Multiple Myeloma 873Leukemia, Myeloid, Acute 773Colorectal Neoplasms 714Neoplasm Metastasis 706Lung Neoplasms 697Melanoma 688Lymphoma 667Leukemia 596Lymphoma, Non-Hodgkin 593Ovarian Neoplasms 536Leukemia, Lymphocytic, Chronic, B-Cell 535Pancreatic Neoplasms 500Precursor Cell Lymphoblastic Leukemia-Lymphoma 485Recurrence 474Myelodysplastic Syndromes 425Lymphoma, Follicular 419Carcinoma, Renal Cell 412Head and Neck Neoplasms 408Glioblastoma 380Lymphoma, Large B-Cell, Diffuse 379Brain Neoplasms 376Hodgkin Disease 354Carcinoma, Hepatocellular 333Squamous Cell Carcinoma of Head and Neck 326Lymphoma, Mantle-Cell 307Sarcoma 286

Interventions

regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Physician Education × Clear all
NCT02287025 2017-10-19

SMART

Bayer

Phase 4 Terminated
23 enrolled 6 charts

Physician Education

Data powered by HemOnc (CC BY 4.0) Colophon âš¡